17 alpha-hydroxyprogesterone caproate has been researched along with Complications, Neoplastic Pregnancy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bokhman, IaV; Chepik, OF; VishnevskiÄ, AS; Volkova, AT | 1 |
Ashkenazy, M; Czernobilsky, B; Kessler, I; Lancet, M; Nahshoni, A | 1 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Complications, Neoplastic Pregnancy
Article | Year |
---|---|
[Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone Congeners; Tamoxifen; Uterine Neoplasms | 1990 |
Ovarian tumors in pregnancy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Adult; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Complications, Neoplastic | 1988 |